Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Digital Therapeutics Market Size Forecast: How Big Could The Market Get By 2030?
The digital therapeutics market has seen remarkable growth in recent years. It is anticipated to expand from $10.93 billion in 2025 to $14.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 28.3%. This historical expansion can be attributed to several factors including the rising adoption of smartphones in healthcare, enhanced acceptance of digital health solutions, the widening scope of telemedicine services, early regulatory endorsements for digital therapeutics, and an increasing prevalence of chronic diseases.
The digital therapeutics market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $37.82 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 28.1%. This projected market acceleration stems from factors such as enhanced reimbursement avenues for digital therapeutics, a greater need for tailored digital healthcare, the proliferation of AI-powered treatment platforms, an increase in collaborations between healthcare providers and technology companies, and a heightened emphasis on proactive digital health strategies. Key developments anticipated during this period include a greater uptake of software-based therapeutic tools, the growing incorporation of wearable health devices, expanded utilization of remote patient monitoring systems, the development of more evidence-backed digital care initiatives, and a stronger concentration on individualized treatment approaches.
Get A Free Sample Report With In-Depth Market Insights:
Digital Therapeutics Market Development Factors: What’s Supporting Demand?
The increasing occurrence of chronic illnesses is anticipated to drive the expansion of the digital therapeutics market in the future. Chronic diseases are persistent conditions typically lasting a year or longer, necessitating continuous medical care or restricting daily activities, or both. Digital therapeutics involve software-based interventions that provide evidence-backed therapeutic solutions to patients, improving chronic disease management and offering more treatment alternatives. For instance, in March 2025, the Office for Health Improvement & Disparities (OHID), a UK-based unit of the Department of Health and Social Care, reported that the prevalence of type 2 diabetes recorded by GPs in adults aged 17 and over in England was 7.0% in March 2024, an increase from 6.8% in March 2023. Consequently, the rising prevalence of chronic diseases fuels the growth of the digital therapeutics market.
Digital Therapeutics Market Segmentation And Category Overview
The digital therapeutics market covered in this report is segmented –
1) By Product: Software, Devices
2) By Sales Channel: Business-To-Business (B2B), Business-To-Consumers (B2C)
3) By Application: Preventive Applications, Treatment Or Care-Related Applications
Subsegments:
1) By Software: Mobile Applications, Web-Based Platforms, Digital Therapeutics Software
2) By Devices: Wearable Devices, Biosensors, Digital Therapeutic Devices
Digital Therapeutics Market Transformation Trends: What Innovations Are Driving Change?
Key players within the digital therapeutics market are focusing on developing technological advancements, notably prescription-only digital behavioral therapy platforms, to enhance treatment accessibility, improve patient engagement, and provide clinically validated outcomes. A prescription-only digital behavioral therapy platform employs software-based interventions provided through devices like smartphones or tablets. It integrates evidence-based modules such as cognitive behavioral therapy (CBT), remote monitoring, and interactive goal tracking, thereby facilitating scalable, drug-free disease management and personalized patient support. For instance, in July 2023, Better Therapeutics, a US-based prescription digital therapeutics company, launched AspyreRx (formerly BT-001), a digital therapeutic for type 2 diabetes. The product delivers a 90-day self-paced program through a smartphone app, featuring weekly CBT lessons, personalized goal-setting, and tracking of blood glucose and lifestyle data; clinical trials demonstrated sustained reductions in HbA1c, weight improvement, and better quality-of-life outcomes.
Digital Therapeutics Market Key Participants And Competitive Landscape
Major companies operating in the digital therapeutics market are Omada Health Inc., WellDoc Inc., 2Morrow Inc., Propeller Health, Pear Therapeutics, Canary Health Inc., Noom Health Inc., Akili Interactive Labs, Better Therapeutics, Happify Health, Kaia Health, Medtronic plc, Teladoc Health Inc., Fitbit Health Solutions, EMulate Therapeutics, BigHealth, DarioHealth, IQVIA, JOGO Health, SilverCloud Health, Biofourmis Inc., Prosoma, Virta Health Corp., One Drop Inc., Lark Health, Xealth, CogniFit Ltd.
View The Full Digital Therapeutics Market Report:
Digital Therapeutics Market Geographic Analysis: Where Is Demand Rising Fastest?
North America was the largest region in the digital therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
